Gilead and Rosa present at the 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention

Gilead Sciences and Rosa will describe a collaborative study in a talk entitled “A Large Population Pharmacokinetic Evaluation of the Influence of Demographic and HIV Disease Factors on the Pharmacokinetics of Elvitegravir, Cobicistat, and Tenofovir” at the 7th International AIDS Society conference (AIS 2013) in Kuala Lumpur, Malaysia from June 30 to July 3, 2013. (Abstract)